203 related articles for article (PubMed ID: 31931840)
1. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
[TBL] [Abstract][Full Text] [Related]
2. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Fabry disease among Turkish dialysis patients: Data from hemodialysis centers in Bursa province.
Sayilar EI; Ayar Y; Yavuz M
Clin Nephrol; 2016 Mar; 85(3):165-72. PubMed ID: 26833297
[TBL] [Abstract][Full Text] [Related]
4. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
[TBL] [Abstract][Full Text] [Related]
5. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Fabry disease in male dialysis patients: Argentinean screening study.
Frabasil J; Durand C; Sokn S; Gaggioli D; Carozza P; Carabajal R; Politei J; Schenone AB
JIMD Rep; 2019 Jul; 48(1):45-52. PubMed ID: 31392112
[TBL] [Abstract][Full Text] [Related]
7. Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).
Marrone G; Angelico R; Di Lauro M; Sargentini E; Manzia TM; Tisone G; Mitterhofer AP; Della Morte Canosci D; Tesauro M; Di Daniele N; Noce A
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3134-3141. PubMed ID: 37070916
[TBL] [Abstract][Full Text] [Related]
8. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
[TBL] [Abstract][Full Text] [Related]
9. Screening for Fabry disease in male patients with end-stage renal disease in western France.
Vigneau C; Germain DP; Larmet D; Jabbour F; Hourmant M;
Nephrol Ther; 2021 Jun; 17(3):180-184. PubMed ID: 33994139
[TBL] [Abstract][Full Text] [Related]
10. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
[TBL] [Abstract][Full Text] [Related]
11. alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease.
Linthorst GE; Hollak CE; Korevaar JC; Van Manen JG; Aerts JM; Boeschoten EW
Nephrol Dial Transplant; 2003 Aug; 18(8):1581-4. PubMed ID: 12897098
[TBL] [Abstract][Full Text] [Related]
12. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Fabry's disease within hemodialysis patients in Spain.
Herrera J; Miranda CS
Clin Nephrol; 2014 Feb; 81(2):112-20. PubMed ID: 24365053
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Fabry disease in male and female haemodialysis patients in Spain.
Gaspar P; Herrera J; Rodrigues D; Cerezo S; Delgado R; Andrade CF; Forascepi R; Macias J; del Pino MD; Prados MD; de Alegria PR; Torres G; Vidau P; Sá-Miranda MC
BMC Med Genet; 2010 Feb; 11():19. PubMed ID: 20122163
[TBL] [Abstract][Full Text] [Related]
15. Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nagata A; Nasu M; Kaida Y; Nakayama Y; Kurokawa Y; Nakamura N; Shibata R; Hazama T; Tsukimura T; Togawa T; Saito S; Sakuraba H; Fukami K
Nephrol Dial Transplant; 2021 Dec; 37(1):115-125. PubMed ID: 34282462
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
[TBL] [Abstract][Full Text] [Related]
17. Screening for Fabry disease among male patients on hemodialysis in Awaji Island.
Shimizu M; Fujii H; Kono K; Watanabe K; Goto S; Nozu K; Nakamura K; Nishi S
Ther Apher Dial; 2022 Dec; 26(6):1187-1192. PubMed ID: 35261182
[TBL] [Abstract][Full Text] [Related]
18. The Frequency of Fabry Disease among Young Cryptogenic Stroke Patients in the City of Sakarya.
Gündoğdu AA; Kotan D; Alemdar M
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1334-1340. PubMed ID: 28283366
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for Fabry disease in the north-west of Spain.
Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR
Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
